The global Anti-obesity Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Anti-obesity Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-obesity Medicine.

Report Scope

The Anti-obesity Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-obesity Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-obesity Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Anti-obesity Medicine Market Report

Report Metric	Details
Report Name	Anti-obesity Medicine Market
CAGR	5%
Segment by Type	Prescription Drugs OTC Drugs
Segment by Application	Men Women
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai, GlaxoSmithKline, Orexigen Therapeutics, Vivus, Pfizer, Roche, Merck, Novo Nordisk
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-obesity Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-obesity Medicine Market report?

Ans: The main players in the Anti-obesity Medicine Market are Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai, GlaxoSmithKline, Orexigen Therapeutics, Vivus, Pfizer, Roche, Merck, Novo Nordisk

What are the Application segmentation covered in the Anti-obesity Medicine Market report?

Ans: The Applications covered in the Anti-obesity Medicine Market report are Men, Women

What are the Type segmentation covered in the Anti-obesity Medicine Market report?

Ans: The Types covered in the Anti-obesity Medicine Market report are Prescription Drugs, OTC Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Prescription Drugs

1.2.3 OTC Drugs

1.3 Market by Application

1.3.1 Global Anti-obesity Medicine Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Men

1.3.3 Women

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Anti-obesity Medicine Market Perspective (2019-2030)

2.2 Anti-obesity Medicine Growth Trends by Region

2.2.1 Global Anti-obesity Medicine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Anti-obesity Medicine Historic Market Size by Region (2019-2024)

2.2.3 Anti-obesity Medicine Forecasted Market Size by Region (2025-2030)

2.3 Anti-obesity Medicine Market Dynamics

2.3.1 Anti-obesity Medicine Industry Trends

2.3.2 Anti-obesity Medicine Market Drivers

2.3.3 Anti-obesity Medicine Market Challenges

2.3.4 Anti-obesity Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Anti-obesity Medicine Players by Revenue

3.1.1 Global Top Anti-obesity Medicine Players by Revenue (2019-2024)

3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2019-2024)

3.2 Global Anti-obesity Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Anti-obesity Medicine Revenue

3.4 Global Anti-obesity Medicine Market Concentration Ratio

3.4.1 Global Anti-obesity Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anti-obesity Medicine Revenue in 2023

3.5 Anti-obesity Medicine Key Players Head office and Area Served

3.6 Key Players Anti-obesity Medicine Product Solution and Service

3.7 Date of Enter into Anti-obesity Medicine Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-obesity Medicine Breakdown Data by Type

4.1 Global Anti-obesity Medicine Historic Market Size by Type (2019-2024)

4.2 Global Anti-obesity Medicine Forecasted Market Size by Type (2025-2030)

5 Anti-obesity Medicine Breakdown Data by Application

5.1 Global Anti-obesity Medicine Historic Market Size by Application (2019-2024)

5.2 Global Anti-obesity Medicine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Anti-obesity Medicine Market Size (2019-2030)

6.2 North America Anti-obesity Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Anti-obesity Medicine Market Size by Country (2019-2024)

6.4 North America Anti-obesity Medicine Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Anti-obesity Medicine Market Size (2019-2030)

7.2 Europe Anti-obesity Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Anti-obesity Medicine Market Size by Country (2019-2024)

7.4 Europe Anti-obesity Medicine Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Anti-obesity Medicine Market Size (2019-2030)

8.2 Asia-Pacific Anti-obesity Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Anti-obesity Medicine Market Size by Region (2019-2024)

8.4 Asia-Pacific Anti-obesity Medicine Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Anti-obesity Medicine Market Size (2019-2030)

9.2 Latin America Anti-obesity Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Anti-obesity Medicine Market Size by Country (2019-2024)

9.4 Latin America Anti-obesity Medicine Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Anti-obesity Medicine Market Size (2019-2030)

10.2 Middle East & Africa Anti-obesity Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Anti-obesity Medicine Market Size by Country (2019-2024)

10.4 Middle East & Africa Anti-obesity Medicine Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alizyme

11.1.1 Alizyme Company Detail

11.1.2 Alizyme Business Overview

11.1.3 Alizyme Anti-obesity Medicine Introduction

11.1.4 Alizyme Revenue in Anti-obesity Medicine Business (2019-2024)

11.1.5 Alizyme Recent Development

11.2 Amylin Pharmaceuticals

11.2.1 Amylin Pharmaceuticals Company Detail

11.2.2 Amylin Pharmaceuticals Business Overview

11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Introduction

11.2.4 Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2019-2024)

11.2.5 Amylin Pharmaceuticals Recent Development

11.3 Arena Pharmaceuticals

11.3.1 Arena Pharmaceuticals Company Detail

11.3.2 Arena Pharmaceuticals Business Overview

11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Introduction

11.3.4 Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2019-2024)

11.3.5 Arena Pharmaceuticals Recent Development

11.4 Boehringer Ingelheim

11.4.1 Boehringer Ingelheim Company Detail

11.4.2 Boehringer Ingelheim Business Overview

11.4.3 Boehringer Ingelheim Anti-obesity Medicine Introduction

11.4.4 Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2019-2024)

11.4.5 Boehringer Ingelheim Recent Development

11.5 Eisai

11.5.1 Eisai Company Detail

11.5.2 Eisai Business Overview

11.5.3 Eisai Anti-obesity Medicine Introduction

11.5.4 Eisai Revenue in Anti-obesity Medicine Business (2019-2024)

11.5.5 Eisai Recent Development

11.6 GlaxoSmithKline

11.6.1 GlaxoSmithKline Company Detail

11.6.2 GlaxoSmithKline Business Overview

11.6.3 GlaxoSmithKline Anti-obesity Medicine Introduction

11.6.4 GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2019-2024)

11.6.5 GlaxoSmithKline Recent Development

11.7 Orexigen Therapeutics

11.7.1 Orexigen Therapeutics Company Detail

11.7.2 Orexigen Therapeutics Business Overview

11.7.3 Orexigen Therapeutics Anti-obesity Medicine Introduction

11.7.4 Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2019-2024)

11.7.5 Orexigen Therapeutics Recent Development

11.8 Vivus

11.8.1 Vivus Company Detail

11.8.2 Vivus Business Overview

11.8.3 Vivus Anti-obesity Medicine Introduction

11.8.4 Vivus Revenue in Anti-obesity Medicine Business (2019-2024)

11.8.5 Vivus Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Detail

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Anti-obesity Medicine Introduction

11.9.4 Pfizer Revenue in Anti-obesity Medicine Business (2019-2024)

11.9.5 Pfizer Recent Development

11.10 Roche

11.10.1 Roche Company Detail

11.10.2 Roche Business Overview

11.10.3 Roche Anti-obesity Medicine Introduction

11.10.4 Roche Revenue in Anti-obesity Medicine Business (2019-2024)

11.10.5 Roche Recent Development

11.11 Merck

11.11.1 Merck Company Detail

11.11.2 Merck Business Overview

11.11.3 Merck Anti-obesity Medicine Introduction

11.11.4 Merck Revenue in Anti-obesity Medicine Business (2019-2024)

11.11.5 Merck Recent Development

11.12 Novo Nordisk

11.12.1 Novo Nordisk Company Detail

11.12.2 Novo Nordisk Business Overview

11.12.3 Novo Nordisk Anti-obesity Medicine Introduction

11.12.4 Novo Nordisk Revenue in Anti-obesity Medicine Business (2019-2024)

11.12.5 Novo Nordisk Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Alizyme

Amylin Pharmaceuticals

Arena Pharmaceuticals

Boehringer Ingelheim

Eisai Co Ltd

GlaxoSmithKline PLC

Orexigen Therapeutics

List of Tables

Table 1. Global Anti-obesity Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Prescription Drugs

Table 3. Key Players of OTC Drugs

Table 4. Global Anti-obesity Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Anti-obesity Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Anti-obesity Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Anti-obesity Medicine Market Share by Region (2019-2024)

Table 8. Global Anti-obesity Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Anti-obesity Medicine Market Share by Region (2025-2030)

Table 10. Anti-obesity Medicine Market Trends

Table 11. Anti-obesity Medicine Market Drivers

Table 12. Anti-obesity Medicine Market Challenges

Table 13. Anti-obesity Medicine Market Restraints

Table 14. Global Anti-obesity Medicine Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Anti-obesity Medicine Market Share by Players (2019-2024)

Table 16. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Medicine as of 2023)

Table 17. Ranking of Global Top Anti-obesity Medicine Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Anti-obesity Medicine Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Anti-obesity Medicine Product Solution and Service

Table 21. Date of Enter into Anti-obesity Medicine Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Anti-obesity Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Anti-obesity Medicine Revenue Market Share by Type (2019-2024)

Table 25. Global Anti-obesity Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Anti-obesity Medicine Revenue Market Share by Type (2025-2030)

Table 27. Global Anti-obesity Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Anti-obesity Medicine Revenue Market Share by Application (2019-2024)

Table 29. Global Anti-obesity Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Anti-obesity Medicine Revenue Market Share by Application (2025-2030)

Table 31. North America Anti-obesity Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Anti-obesity Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Anti-obesity Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Anti-obesity Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Anti-obesity Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Anti-obesity Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Anti-obesity Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Anti-obesity Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Anti-obesity Medicine Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Anti-obesity Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Anti-obesity Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Anti-obesity Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Anti-obesity Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Anti-obesity Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Anti-obesity Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 46. Alizyme Company Detail

Table 47. Alizyme Business Overview

Table 48. Alizyme Anti-obesity Medicine Product

Table 49. Alizyme Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 50. Alizyme Recent Development

Table 51. Amylin Pharmaceuticals Company Detail

Table 52. Amylin Pharmaceuticals Business Overview

Table 53. Amylin Pharmaceuticals Anti-obesity Medicine Product

Table 54. Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 55. Amylin Pharmaceuticals Recent Development

Table 56. Arena Pharmaceuticals Company Detail

Table 57. Arena Pharmaceuticals Business Overview

Table 58. Arena Pharmaceuticals Anti-obesity Medicine Product

Table 59. Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 60. Arena Pharmaceuticals Recent Development

Table 61. Boehringer Ingelheim Company Detail

Table 62. Boehringer Ingelheim Business Overview

Table 63. Boehringer Ingelheim Anti-obesity Medicine Product

Table 64. Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 65. Boehringer Ingelheim Recent Development

Table 66. Eisai Company Detail

Table 67. Eisai Business Overview

Table 68. Eisai Anti-obesity Medicine Product

Table 69. Eisai Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 70. Eisai Recent Development

Table 71. GlaxoSmithKline Company Detail

Table 72. GlaxoSmithKline Business Overview

Table 73. GlaxoSmithKline Anti-obesity Medicine Product

Table 74. GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 75. GlaxoSmithKline Recent Development

Table 76. Orexigen Therapeutics Company Detail

Table 77. Orexigen Therapeutics Business Overview

Table 78. Orexigen Therapeutics Anti-obesity Medicine Product

Table 79. Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 80. Orexigen Therapeutics Recent Development

Table 81. Vivus Company Detail

Table 82. Vivus Business Overview

Table 83. Vivus Anti-obesity Medicine Product

Table 84. Vivus Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 85. Vivus Recent Development

Table 86. Pfizer Company Detail

Table 87. Pfizer Business Overview

Table 88. Pfizer Anti-obesity Medicine Product

Table 89. Pfizer Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 90. Pfizer Recent Development

Table 91. Roche Company Detail

Table 92. Roche Business Overview

Table 93. Roche Anti-obesity Medicine Product

Table 94. Roche Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 95. Roche Recent Development

Table 96. Merck Company Detail

Table 97. Merck Business Overview

Table 98. Merck Anti-obesity Medicine Product

Table 99. Merck Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 100. Merck Recent Development

Table 101. Novo Nordisk Company Detail

Table 102. Novo Nordisk Business Overview

Table 103. Novo Nordisk Anti-obesity Medicine Product

Table 104. Novo Nordisk Revenue in Anti-obesity Medicine Business (2019-2024) & (US$ Million)

Table 105. Novo Nordisk Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Anti-obesity Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Anti-obesity Medicine Market Share by Type: 2023 VS 2030

Figure 3. Prescription Drugs Features

Figure 4. OTC Drugs Features

Figure 5. Global Anti-obesity Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Anti-obesity Medicine Market Share by Application: 2023 VS 2030

Figure 7. Men Case Studies

Figure 8. Women Case Studies

Figure 9. Anti-obesity Medicine Report Years Considered

Figure 10. Global Anti-obesity Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Anti-obesity Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Anti-obesity Medicine Market Share by Region: 2023 VS 2030

Figure 13. Global Anti-obesity Medicine Market Share by Players in 2023

Figure 14. Global Top Anti-obesity Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Medicine as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Anti-obesity Medicine Revenue in 2023

Figure 16. North America Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Anti-obesity Medicine Market Share by Country (2019-2030)

Figure 18. United States Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Anti-obesity Medicine Market Share by Country (2019-2030)

Figure 22. Germany Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Anti-obesity Medicine Market Share by Region (2019-2030)

Figure 30. China Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Anti-obesity Medicine Market Share by Country (2019-2030)

Figure 38. Mexico Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Anti-obesity Medicine Market Share by Country (2019-2030)

Figure 42. Turkey Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Anti-obesity Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Alizyme Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 45. Amylin Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 46. Arena Pharmaceuticals Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 47. Boehringer Ingelheim Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 48. Eisai Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 49. GlaxoSmithKline Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 50. Orexigen Therapeutics Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 51. Vivus Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 52. Pfizer Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 53. Roche Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 54. Merck Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 55. Novo Nordisk Revenue Growth Rate in Anti-obesity Medicine Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions